China: review colorant scope when GB 2760 changes

This is a China-specific review workflow

GB 2760 is a Chinese standard. A version or related-document change does not automatically validate or invalidate every existing color formula. This article outlines how to compare the applicable Chinese evidence and company records; it does not supply maximum doses or a product compliance determination, and it does not establish permission in another market.

Lock identity and applicable dates

Record the destination, product, food category, intended function, formula stage and proposed label. Separate the commercial name into formal substances, blended ingredients, carriers, auxiliaries and model/specification. One marketed blend may require several mappings.

Keep the official announcement, standard text, amendments and database entry associated with their applicable version and access date. A year in a title cannot summarize every applicability question. Supplier willingness to sell or a successful dispersion trial does not supply regulatory evidence.

Compare with the company’s existing records

• Obtain original National Health Commission announcements, standard text or the Chinese national food-safety standards data-platform records.
• Map formal identities to the actual food category and conditions, marking each field confirmed, pending or not applicable.
• Compare the identified differences with the current formula, draft label, procurement documents and historical internal approvals.
• Retain links, version and access date so the comparison can be reproduced.
• Have the responsible regulatory/quality person review and sign; reopen when market, formula, supplier or standard changes.

Minimum four-column review

• A: earlier version/current internal basis, including original standard, announcement, version and access date.
• B: identity — formal name, identifier, blend composition, carrier and specification.
• C: use — target food category, function, conditions and label requirements.
• D: decision record — evidence links, unresolved issues, responsible reviewer and follow-up.
• A missing column means pending regulatory review. Do not replace gaps with a search result, spoken supplier assurance or another market’s conclusion.

Handle searches and differences conservatively

Failure to find a trade name may mean the name, identifier, category or search route is wrong. Return to the formal composition and original entry; do not automatically record “prohibited.” Likewise a new edition’s existence does not prove that all color entries changed.

Keep technical feasibility, supplier identity evidence and regulatory/label conclusions distinct. Use secondary interpretations only to locate primary documents. Preserve both confirmed and pending states, without automatically filling a dose or scope. The result should show the exact evidence and reviewer behind any action on a real formula.

Before commercial use

Confirm the exact product through supplier documentation, real-formula trials, pilot and shelf-life validation, and destination-market review. Process settings and use levels depend on that assessment.